The results indicate that anandamide-mediated signaling at CB1 receptors, driven by oxytocin, controls social reward. Deficits in this signaling mechanism may contribute to social impairment in autism spectrum disorders and might offer an avenue to treat these conditions.
Link: Endocannabinoid Signaling Mediates Oxytocin-driven Social Reward
Year: 2015
DOI: 10.1073/pnas.1509795112
Possible to probable range of efficacy of cannabis for treatment of Autism according to the results found in this study.
Anadamide and oxytocin.